119 related articles for article (PubMed ID: 7521758)
1. Cell-cycle dependent alternative splicing of the tenascin primary transcript.
Borsi L; Balza E; Castellani P; Carnemolla B; Ponassi M; Querzé G; Zardi L
Cell Adhes Commun; 1994 Jan; 1(4):307-17. PubMed ID: 7521758
[TBL] [Abstract][Full Text] [Related]
2. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Borsi L; Carnemolla B; Nicolò G; Spina B; Tanara G; Zardi L
Int J Cancer; 1992 Nov; 52(5):688-92. PubMed ID: 1385335
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung.
Zhao Y; Young SL
Am J Physiol; 1995 Feb; 268(2 Pt 1):L173-80. PubMed ID: 7532367
[TBL] [Abstract][Full Text] [Related]
4. Tenascin isoforms: possible targets for diagnosis and therapy of cancer and mechanisms regulating their expression.
Leprini A; Querzé G; Zardi L
Perspect Dev Neurobiol; 1994; 2(1):117-23. PubMed ID: 7530138
[TBL] [Abstract][Full Text] [Related]
5. Qualitative and quantitative changes of human tenascin expression in transformed lung fibroblast and lung tumor tissues: comparison with fibronectin.
Oyama F; Hirohashi S; Shimosato Y; Titani K; Sekiguchi K
Cancer Res; 1991 Sep; 51(18):4876-81. PubMed ID: 1716516
[TBL] [Abstract][Full Text] [Related]
6. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C.
Chung CY; Erickson HP
J Cell Biol; 1994 Jul; 126(2):539-48. PubMed ID: 7518469
[TBL] [Abstract][Full Text] [Related]
7. Extracellular pH controls pre-mRNA alternative splicing of tenascin-C in normal, but not in malignantly transformed, cells.
Borsi L; Allemanni G; Gaggero B; Zardi L
Int J Cancer; 1996 May; 66(5):632-5. PubMed ID: 8647625
[TBL] [Abstract][Full Text] [Related]
8. Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.
Siri A; Knäuper V; Veirana N; Caocci F; Murphy G; Zardi L
J Biol Chem; 1995 Apr; 270(15):8650-4. PubMed ID: 7536739
[TBL] [Abstract][Full Text] [Related]
9. Extracellular matrix proteins in colorectal carcinomas. Expression of tenascin and fibronectin isoforms.
Hauptmann S; Zardi L; Siri A; Carnemolla B; Borsi L; Castellucci M; Klosterhalfen B; Hartung P; Weis J; Stöcker G
Lab Invest; 1995 Aug; 73(2):172-82. PubMed ID: 7543628
[TBL] [Abstract][Full Text] [Related]
10. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts.
Tremble P; Chiquet-Ehrismann R; Werb Z
Mol Biol Cell; 1994 Apr; 5(4):439-53. PubMed ID: 7519905
[TBL] [Abstract][Full Text] [Related]
11. The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C.
Matsumoto K; Saga Y; Ikemura T; Sakakura T; Chiquet-Ehrismann R
J Cell Biol; 1994 Apr; 125(2):483-93. PubMed ID: 7512972
[TBL] [Abstract][Full Text] [Related]
12. Human tenascin: primary structure, pre-mRNA splicing patterns and localization of the epitopes recognized by two monoclonal antibodies.
Siri A; Carnemolla B; Saginati M; Leprini A; Casari G; Baralle F; Zardi L
Nucleic Acids Res; 1991 Feb; 19(3):525-31. PubMed ID: 1707164
[TBL] [Abstract][Full Text] [Related]
13. The alternative splicing pattern of the tenascin-C pre-mRNA is controlled by the extracellular pH.
Borsi L; Balza E; Gaggero B; Allemanni G; Zardi L
J Biol Chem; 1995 Mar; 270(11):6243-5. PubMed ID: 7534307
[TBL] [Abstract][Full Text] [Related]
14. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin.
Murphy-Ullrich JE; Lightner VA; Aukhil I; Yan YZ; Erickson HP; Höök M
J Cell Biol; 1991 Nov; 115(4):1127-36. PubMed ID: 1720121
[TBL] [Abstract][Full Text] [Related]
15. Production and characterization of monoclonal antibodies specific for different epitopes of human tenascin.
Balza E; Siri A; Ponassi M; Caocci F; Linnala A; Virtanen I; Zardi L
FEBS Lett; 1993 Oct; 332(1-2):39-43. PubMed ID: 7691659
[TBL] [Abstract][Full Text] [Related]
16. Characterization of functional domains of the tenascin-R (restrictin) polypeptide: cell attachment site, binding with F11, and enhancement of F11-mediated neurite outgrowth by tenascin-R.
Nörenberg U; Hubert M; Brümmendorf T; Tárnok A; Rathjen FG
J Cell Biol; 1995 Jul; 130(2):473-84. PubMed ID: 7615642
[TBL] [Abstract][Full Text] [Related]
17. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways.
Rettig WJ; Erickson HP; Albino AP; Garin-Chesa P
J Cell Sci; 1994 Feb; 107 ( Pt 2)():487-97. PubMed ID: 7515896
[TBL] [Abstract][Full Text] [Related]
18. Murine tenascin: cDNA cloning, structure and temporal expression of isoforms.
Saga Y; Tsukamoto T; Jing N; Kusakabe M; Sakakura T
Gene; 1991 Aug; 104(2):177-85. PubMed ID: 1717349
[TBL] [Abstract][Full Text] [Related]
19. Steady-state levels of different tenascin mRNAs in various normal human tissues.
Borsi L; Carnemolla B; Ponassi M; Zardi L
Cell Biol Int; 1993 Mar; 17(3):325-9. PubMed ID: 7685649
[TBL] [Abstract][Full Text] [Related]
20. Neuronal cell adhesion molecule contactin/F11 binds to tenascin via its immunoglobulin-like domains.
Zisch AH; D'Alessandri L; Ranscht B; Falchetto R; Winterhalter KH; Vaughan L
J Cell Biol; 1992 Oct; 119(1):203-13. PubMed ID: 1382076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
